CARLOS
TAXONERA SAMSO
Profesor asociado de Ciencias de la Salud
Universidad de Alcalá
Alcalá de Henares, EspañaPublicacions en col·laboració amb investigadors/es de Universidad de Alcalá (5)
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2020
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12
2008
-
Open-label infliximab therapy in ulcerative colitis: A multicenter survey of results and predictors of response
Hepato-Gastroenterology, Vol. 55, Núm. 86-87, pp. 1609-1614
2007
-
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease
Inflammatory Bowel Diseases, Vol. 13, Núm. 5, pp. 585-590